Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

601

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

601 results for “Withdrawal”

Learn how ShareScore rates datasets ↗
zenodo28/100

Reduced Complexity of Quasispecies in HBV Surface and Polymerase Genes at Relapses after Antiviral Withdrawal

<p><strong>Figure S1.</strong> The clinical courses of patients included in this study. The longitudinal data of 5 ETV-<strong> (A)</strong> and 2 TDF- <strong>(B)</strong> treated CHB patients are plotted. Black horizontal bar to the top, time-periods when HBeAg was positive; black triangles, time-points when serum samples were obtained before NAs; grey triangles, time-points when serum samples were obtained at relapse after NA withdrawal; black arrows, time-points when patients started to receive NAs; grey arrows, time-points when NAs were withdrawn; black circles, HBV-DNA levels; grey squares, ALT levels.</p> <p>&nbsp;</p> <p><strong>Figure S2.</strong> The HBV genetic heterogeneity in the surface gene analyzed by deep-sequencing. <strong>(A)</strong> The distribution of well-defined functional domains within the surface gene. I, transmembrane domain I (TMD I: s8-22); cytosolic loop (CL: s22-80); II, transmembrane domain II (TMD II: s80-100); major hydrophilic region (MHR: s99-169); antigenic determinant (a determinant) region (located within MHR: s124-147); III, transmembrane domain III (TMD III: s170-192); IV, transmembrane domain IV (TMD IV: s202-224); hydrophobic C-terminus region (HCR: s170-226, includes TMD III-IV and the loop between them). The surface gene variants identified from ETV-treated patients are listed in <strong>(B)</strong> while those identified from TDF-treated patients are listed in <strong>(C)</strong>. Baseline, samples obtained from patients before antiviral treatments; Relapse, samples obtained from patients with virological reactivation after NA withdrawal.</p> <p>&nbsp;</p> <p><strong>Figure S3.</strong> The viral genetic variations in the reverse transcriptase domain of the polymerase gene analyzed by deep-sequencing. <strong>(A)</strong> The functional motifs in the reverse transcriptase domain. G, box G or box I; F, F box or box II: rt37-47; A, box A: rt75-90; B, box B: rt159-182; C, box C: rt201-210; D, box D: rt230-241; E, box E: rt247-257. The variants in the reverse transcriptase domain identified from ETV-treated patients are listed in <strong>(B)</strong> while those identified from TDF-treated patients are listed in <strong>(C)</strong>. Baseline, samples derived from patients before antiviral treatment; Relapse, samples derived from patients with virological relapses after NA withdrawal.</p>

opencc-by-2.0Jun 2020View details →
zenodo28/100

Withdrawing Performance Indicators: Retrospective Analysis of General Practice Performance Under the UKs Quality and Outcomes Framework

<p>No description provided.</p>

openother-openMay 2014View details →
zenodo28/100

Trials of herbal compounds for opiate withdrawal

<p>A table showing the trials for compounds impacting opiate withdrawal symptoms in human studies (Table 1) and animal models (Table 2)</p>

opencc-by-4.0Nov 2024View details →
zenodo28/100

How is the nociceptive withdrawal reflex influenced by increasing doses of propofol in pigs?

<p>The files contain the nocicpetive withdrawal reflex thresholds for each single pig and for each single day.<br> They have been recorded continuously (for more details see main text) from the beginning to the end of the experiment.</p> <p>Each Excel file is dedicated to one pig. In each Excel file, there are 3 worksheets that refer to each experimental day.<br> All the parameters recorded from the Dolosys have been reported (data are presented as downloaded from the device), namely:</p> <p>stimulus_no date time stimulus_intensity [mA] threshold [mA] imp_stim [ohm] imp_emg_red [ohm] imp_emg_black [ohm] imp_emg_white [ohm] noise_level threshold_reliability scoring_value scoring_cutoff_value noise_max [uV] noise_mean [uV] noise_sd [uV] reflex_max [uV] reflex_mean [uV] reflex_sd [uV] NRS noise_start [ms] noise_end [ms] reflex_start [ms] reflex_end [ms] measured_current [mA] measured_voltage [V]</p>

opencc-by-4.0Sep 2023View details →
ClinicalTrials.gov28/100

Remote Treatment of Alcohol Withdrawal

ClinicalTrials.gov study NCT04858490. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

ClinicalTrials.gov study NCT00707759. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

ClinicalTrials.gov study NCT00210613. IPD Sharing: Not stated. Countries: 0. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior

ClinicalTrials.gov study NCT03840694. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study

ClinicalTrials.gov study NCT00653263. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients

ClinicalTrials.gov study NCT06589973. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

ClinicalTrials.gov study NCT06108544. IPD Sharing: YES. Countries: 16. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Progesterone for Cannabis Withdrawal

ClinicalTrials.gov study NCT03430050. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder

ClinicalTrials.gov study NCT07079826. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

ClinicalTrials.gov study NCT04316559. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Neural Substrates in Nicotine Withdrawal

ClinicalTrials.gov study NCT01001520. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

tAN to Mitigate Withdrawal Behaviors in Neonates

ClinicalTrials.gov study NCT04588519. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

ClinicalTrials.gov study NCT04070157. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

ClinicalTrials.gov study NCT00374803. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer

ClinicalTrials.gov study NCT04916262. IPD Sharing: Not stated. Countries: 0. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

ClinicalTrials.gov study NCT02643355. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record